Investor Calendar Invites You to the Capricor Therapeutics Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 15, 2016

LOS ANGELES, CA / ACCESSWIRE / August 15, 2016 / Capricor Therapeutics, Inc. (NASDAQ: CAPR) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held August 15, 2016 at 4:30 PM Eastern Time.

To participate in this event, dial 800-862-7924 domestically, or 785-424-1047 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=175240 or on the Capricor Therapeutics website (http://capricor.com/news/events/).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or http://capricor.com/news/events/.

About Capricor Therapeutics

Capricor Therapeutics, Inc. (CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics. Capricor has two product candidates under clinical investigation: CAP-1002, a cardiac cell therapy, and Cenderitide, a dual natriuretic peptide receptor agonist. CAP-1002 is in development for the treatment of post myocardial infarction, advanced heart failure and Duchenne muscular dystrophy-associated cardiomyopathy. Cenderitide is in development for the outpatient treatment of heart failure as well as other potential indications. In addition, Capricor is evaluating its exosomes platform technology for cardiac diseases and other therapeutic areas. For additional information, visit www.capricor.com.

SOURCE: Investor Calendar

ReleaseID: 443717